Fast Five Quiz: Noncoronary Atherosclerosis Management

Yasmine S. Ali, MD


March 01, 2021

Measurement of Lp(a) at least once is recommended to identify patients with very high inherited Lp(a) levels > 180 mg/dL (> 430 nmol/L), who may have a lifetime risk for atherosclerotic cardiovascular disease (ASCVD). This risk is equivalent to the risk associated with familial hypercholesterolemia.

Assessment of the coronary artery calcium score with CT can be considered a risk modifier in the cardiovascular risk assessment of asymptomatic individuals at low or moderate risk. Similarly, assessment of carotid and/or femoral arterial plaque burden on arterial ultrasound can be considered a risk modifier in individuals at low or moderate risk.

Vitamin E supplements are not recommended because their benefit has not been proven in this context. Some studies have even suggested that they reduce the effectiveness of antidyslipidemic medications.

Learn more about guidelines for atherosclerosis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.